Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept.

Arthritis Res Ther · 2022 · PMC8848810 · PMID 35172859

Europe PMC DOI

hedged sentence

0.0822

closest p · 1.6× alpha

0.0822

boldest claim

The sentences

showed a trendP = 0.0822so close (0.05 < p ≤ 0.1)

A weighted combined inflammation score >9 showed a trend towards being independently associated with flare at both WD+6mo and WD+12mo (OR 2.91 [0.87, 9.71], P = 0.0822 and OR 3.01 [0.78, 11.65], P = 0.1108, respectively; Fig. 3 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.